SCHEMBL1701715

SCHEMBL1701715

COC(=O)CCCCCCCCN

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.64
PAOX Q6QHF9 4/20 0.56
LMNA P02545 4/20 0.55
ALDH1A1 P00352 2/20 0.55
KMT2A Q03164 2/20 0.52
RECQL P46063 2/20 0.52
MEN1 O00255 1/20 0.52
PLG P00747 1/20 0.52
THRB P10828 1/20 0.52
ALOX15 P16050 1/20 0.52
SLC6A2 P23975 1/20 0.52
SLC6A3 Q01959 1/20 0.52
KDM4E B2RXH2 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.48
NFKB1 P19838 1/20 0.48
BLM P54132 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1147174 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL7545025 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL1235539 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL3208419 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL7545108 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL2822938 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL7541388 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL7548607 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL2128896 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A
SCHEMBL905418 1.00 TSHR (0.64) TSHRPAOXLMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974886-A Macrocyclic lactam compound containing dihydrobenzofuran skeleton and preparation method thereof 国科大杭州高等研究院 2023-04-18 CN claimed
EP-0001914-B1 ANTIBACTERIALLY ACTIVE AMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID AMIDES BEECHAM GROUP PLC (GB) 1981-05-20 EP claimed
US-4200635-A MONIC ACID A AMIDES BEECHAM GROUP LIMITED (GB) 1980-04-29 US claimed
EP-0001914-A2 Antibacterially active amides, process for their preparation and pharmaceutical compositions containing said amides BEECHAM GROUP PLC (GB) 1979-05-16 EP claimed
CN-118255685-A Tricyclic compound, pharmaceutical composition and application thereof 珂阑(上海)医药科技有限公司 2024-06-28 CN disclosed
CN-115141123-B Compound, preparation method thereof and application thereof in preparation of dual inhibitors of histone deacetylase and epoxide hydrolase 沈阳药科大学 2024-05-17 CN disclosed
US-20240024488-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2024-01-25 US disclosed
US-20240024488-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2024-01-25 US disclosed
US-20240024488-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2024-01-25 US disclosed
EP-4247381-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2023-09-27 EP disclosed
CN-116744929-A Compounds and uses thereof 福霍恩治疗公司 2023-09-12 CN disclosed
CN-115974886-A Macrocyclic lactam compound containing dihydrobenzofuran skeleton and preparation method thereof 国科大杭州高等研究院 2023-04-18 CN disclosed
EP-2585432-A1 SYNTHESIS OF OMEGA-AMINO CARBOXYLIC ACIDS AND THEIR ESTERS FROM UNSATURATED FATTY ACID DERIVATIVES Evonik Degussa GmbH (DE) 2013-05-01 EP disclosed
US-8377661-B2 Method for synthesising omega-amino-alkanoic acids or the esters thereof from natural fatty acids ARKEMA FRANCE (FR) 2013-02-19 US disclosed
WO-2011160730-A1 SYNTHESIS OF OMEGA-AMINO CARBOXYLIC ACIDS AND THEIR ESTERS FROM UNSATURATED FATTY ACID DERIVATIVES EVONIK DEGUSSA GMBH (DE) 2011-12-29 WO disclosed
US-20110224454-A1 METHOD FOR THE SYNTHESIS OF AN OMEGA-AMINO ACID OR ESTER STARTING FROM A MONOUNSATURATED FATTY ACID OR ESTER ARKEMA FRANCE (FR) 2011-09-15 US disclosed
US-20110105774-A1 METHOD FOR SYNTHESISING 9-AMINONONANOIC ACID OR THE ESTERS THEREOF FROM NATURAL UNSATURATED FATTY ACIDS ARKEMA FRANCE (FR) 2011-05-05 US disclosed
EP-0001914-B1 ANTIBACTERIALLY ACTIVE AMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID AMIDES BEECHAM GROUP PLC (GB) 1981-05-20 EP disclosed
US-4200635-A MONIC ACID A AMIDES BEECHAM GROUP LIMITED (GB) 1980-04-29 US disclosed
EP-0001914-A2 Antibacterially active amides, process for their preparation and pharmaceutical compositions containing said amides BEECHAM GROUP PLC (GB) 1979-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224454-A1 METHOD FOR THE SYNTHESIS OF AN OMEGA-AMINO ACID OR ESTER STARTING FROM A MONOUNSATURATED FATTY ACID OR ESTER FASN, ELOVL6, ELOVL1 TSHR 3566/4885PAOX 113/4885LMNA 1199/4885
US-20110105774-A1 METHOD FOR SYNTHESISING 9-AMINONONANOIC ACID OR THE ESTERS THEREOF FROM NATURAL UNSATURATED FATTY ACIDS FASN, ALOX5, ALOX15 TSHR 4452/4885PAOX 82/4885LMNA 740/4885
US-20240024488-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB TSHR 4351/4885PAOX 136/4885LMNA 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.